Business Segment Information

6 Months Ended

Apr. 30, 2020

The Company discloses information about its operating segments, which were established based on the way that management organizes segments within the Company for making operating decisions and assessing financial performance. The Company's two operating segments are described below.

•

CooperVision. Competes in the worldwide contact lens market by developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues, with a broad collection of spherical, toric and multifocal contact lenses.


•	CooperSurgical. Competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health, fertility, diagnostics and contraception.

Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results.

Total identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets.

Segment information:



Periods Ended April 30,	Three Months						Six Months
(In millions)	2020			2019			2020			2019
CooperVision net sales by category:
Toric lens	$	133.6		$	155.3		$	288.7		$	301.3
Multifocal lens	45.1			49.7			96.9			98.7
Single-use sphere lens	116.1			135.3			254.2			267.3
Non single-use sphere, other	107.4			143.9			247.6			287.0
Total CooperVision net sales	$	402.2		$	484.2		887.4			954.3
CooperSurgical net sales by category:
Office and surgical products	69.6			105.7			168.0			201.4
Fertility	53.1			64.4			115.7			126.7
CooperSurgical net sales	122.7			170.1			283.7			328.1
Total net sales	$	524.9		$	654.3		$	1,171.1		$	1,282.4
Operating income:
CooperVision	$	67.7		$	125.5		$	190.6		$	241.7
CooperSurgical	(25.6		)	31.1			(23.9		)	38.3
Corporate	(13.5		)	(9.7		)	(27.0		)	(22.2		)
Total operating income	28.6			146.9			139.7			257.8
Interest expense	12.8			18.5			24.4			36.6
Other expense (income), net	6.8			0.3			8.9			(0.7		)
Income before income taxes	$	9.0		$	128.1		$	106.4		$	221.9



(In millions)	April 30, 2020		October 31, 2019
Total identifiable assets:
CooperVision	$	4,140.3	$	3,911.6
CooperSurgical	2,207.4		2,189.8
Corporate	162.2		173.1
Total	$	6,510.0	$	6,274.5

Geographic information:



Periods Ended April 30,	Three Months				Six Months
(In millions)	2020		2019		2020		2019
Net sales to unaffiliated customers by country of domicile:
United States	$	222.5	$	305.9	$	516.0	$	584.9
Europe	178.8		209.5		392.1		419.2
Rest of world	123.7		138.9		263.0		278.3
Total	$	524.9	$	654.3	$	1,171.1	$	1,282.4



(In millions)	April 30, 2020		October 31, 2019
Net property, plant and equipment by country of domicile:
United States	$	674.4	$	626.5
Europe	354.3		358.8
Rest of world	167.3		146.8
Total	$	1,196.1	$	1,132.1